What are the primary concerns regarding PCSK9 Inhibitors?
While PCSK9 inhibitors have been effective in reducing LDL-C levels, concerns exist regarding their safety profile. As with any therapeutic agent, understanding potential side effects and toxicological implications is crucial. Commonly reported side effects include injection site reactions, nasopharyngitis, and, rarely, neurocognitive events.
